Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RANI Rani Therapeutics Holdings Inc
- Stocks
- Healthcare
- NASDAQ: RANI
Price (delayed)
$0.6406
Market cap
$36.86M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.99
Enterprise value
$52.42M
Highlights
The debt has declined by 28% year-on-year and by 14% since the previous quarter
The EPS has increased by 23% YoY and by 6% from the previous quarter
The company's equity has shrunk by 141% YoY
The quick ratio has dropped by 72% year-on-year and by 41% since the previous quarter
Key stats
What are the main financial stats of RANI
Market
Valuations
Earnings
Shares outstanding
57.54M
Market cap
$36.86M
Enterprise value
$52.42M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
17.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
43.68
Revenue
$1.2M
Gross profit
$1.2M
Operating income
-$51.29M
Net income
-$29.8M
EBIT
-$25.12M
EBITDA
-$22.18M
Free cash flow
-$34.54M
Per share
Balance sheet
Liquidity
EPS
-$0.99
EPS diluted
-$0.99
Free cash flow per share
-$1.03
Book value per share
-$0.05
Revenue per share
$0.04
TBVPS
$0.72
Total assets
$24.13M
Total liabilities
$29.47M
Debt
$25.67M
Equity
-$3.06M
Working capital
-$2.35M
Debt to equity
-8.4
Current ratio
0.88
Quick ratio
0.82
Net debt/EBITDA
-0.7
Margins
Efficiency
Dividend
EBITDA margin
-1,848.3%
Gross margin
100%
Net margin
-2,483.3%
Operating margin
-4,274.5%
Return on assets
-80.5%
Return on equity
-2,437%
Return on invested capital
-58.1%
Return on capital employed
-628.8%
Return on sales
-2,093.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RANI stock price
How has the Rani Therapeutics Holdings stock price performed over time
Intraday
12.23%
1 week
-12.25%
1 month
-44.3%
1 year
-88.27%
YTD
-53.24%
QTD
-49.16%
Financial performance
How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$1.2M
Gross profit
$1.2M
Operating income
-$51.29M
Net income
-$29.8M
Gross margin
100%
Net margin
-2,483.3%
The operating income has grown by 19% YoY and by 3.8% from the previous quarter
The operating margin is up by 18% since the previous quarter
RANI's gross profit is up by 17% since the previous quarter
The revenue has grown by 17% from the previous quarter
Price vs fundamentals
How does RANI's price correlate with its fundamentals
Growth
What is Rani Therapeutics Holdings's growth rate over time
Valuation
What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
17.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
43.68
The EPS has increased by 23% YoY and by 6% from the previous quarter
The company's equity has shrunk by 141% YoY
The revenue has grown by 17% from the previous quarter
Efficiency
How efficient is Rani Therapeutics Holdings business performance
RANI's ROIC has plunged by 73% YoY and by 29% from the previous quarter
The ROA has plunged by 61% YoY and by 19% from the previous quarter
The ROS has increased by 14% from the previous quarter
Dividends
What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RANI.
Financial health
How did Rani Therapeutics Holdings financials performed over time
Rani Therapeutics Holdings's total assets is 18% less than its total liabilities
The quick ratio has dropped by 72% year-on-year and by 41% since the previous quarter
The current ratio has shrunk by 72% YoY and by 41% QoQ
The company's debt to equity has shrunk by 156% QoQ
The company's equity has shrunk by 141% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.